These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis]. Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006 [No Abstract] [Full Text] [Related]
8. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides]. Wiemer J; Scherberich JE MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118 [TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin on lipid metabolism in patients with chronic renal failure treated with hemodialysis]. Chmielewska J; Poplawski A Pol Tyg Lek; 1977 Aug; 32(34):1337-40. PubMed ID: 905179 [No Abstract] [Full Text] [Related]
10. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis]. Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225 [TBL] [Abstract][Full Text] [Related]
11. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers. Leblanc M; Lafrance JP; Renald A ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054 [TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to heparin; a case report. Katoh S; Terashima S; Nakahara Y; Yamada H; Tatsukawa H; Ida K; Nakagawa M Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):411-4. PubMed ID: 8341021 [TBL] [Abstract][Full Text] [Related]
13. [Experiences with minimal intermittent heparinization in chronic dialysis patients]. Kovác A; Hünicke G; Bierwisch H Z Urol Nephrol; 1980 May; 73(5):353-9. PubMed ID: 7456802 [TBL] [Abstract][Full Text] [Related]
14. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization]. Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084 [TBL] [Abstract][Full Text] [Related]
15. [Subcutaneous calcium heparin in hemodialysis (author's transl)]. Molinari ML; Zoni G Haematologica; 1975 Dec; 60(4):466-76. PubMed ID: 816716 [No Abstract] [Full Text] [Related]
16. [Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients]. Borawski J; Myśliwiec M Pol Merkur Lekarski; 2006 Aug; 21(122):117-8; discussion 119. PubMed ID: 17144092 [TBL] [Abstract][Full Text] [Related]
17. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients. Low CL; Bailie G; Morgan S; Eisele G Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524 [TBL] [Abstract][Full Text] [Related]
18. [Prothrombin time in long-term hemodialyzed patients. The effect of a single hemodialysis, heparin, protamine and vitamin K]. Koslík S; Ponist J; Takác M; Lapsanská I Cas Lek Cesk; 1983 Feb; 122(5):139-42. PubMed ID: 6831493 [No Abstract] [Full Text] [Related]
19. Sudden collapse during haemodialysis due to immune-mediated heparin-induced thrombocytopaenia. Davenport A Nephrol Dial Transplant; 2006 Jun; 21(6):1721-4. PubMed ID: 16554318 [No Abstract] [Full Text] [Related]
20. Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death. Dreyer G; Lawton P; Jose M Hemodial Int; 2008 Oct; 12(4):431-3. PubMed ID: 19090865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]